Hiromachi, Japan

Kazou Hasegawa

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazou Hasegawa. Retrieved from https://idiyas.com/inventor/kazou-hasegawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 143(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazou Hasegawa: Innovator in Thiazolidine Derivatives

Introduction

Kazou Hasegawa is a notable inventor based in Hiromachi, Japan. He has made significant contributions to the field of chemistry, particularly in the development of thiazolidine derivatives. His work has implications for various applications in pharmaceuticals and related industries.

Latest Patents

Hasegawa holds a patent for thiazolidine derivatives, their preparation, and compositions containing these compounds. The patent details compounds of formula (I), where R¹ and R² can represent hydrogen or C₁-C₅ alkyl groups. This innovation showcases his expertise in creating valuable chemical compounds.

Career Highlights

Kazou Hasegawa is associated with Sankyo Company, Limited, where he has been able to apply his knowledge and skills in a professional setting. His work at the company has allowed him to contribute to advancements in medicinal chemistry and drug development.

Collaborations

Hasegawa has collaborated with notable colleagues, including Takao Yoshioka and Eiici Kitazawa. These partnerships have likely enhanced the scope and impact of his research and innovations.

Conclusion

Kazou Hasegawa is a distinguished inventor whose work on thiazolidine derivatives has made a significant impact in the field of chemistry. His contributions continue to influence the development of new pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…